AKTTYVA THERAPEUTICS
Akttyva Therapeutics develops targeted therapeutics that address cell barrier dysfunction across multiple indications.
AKTTYVA THERAPEUTICS
Industry:
Health Care Therapeutics Wellness
Founded:
2006-01-01
Address:
Mansfield, Massachusetts, United States
Country:
United States
Website Url:
http://www.akttyva.com
Total Employee:
1+
Status:
Active
Contact:
+1-617-821-7095
Total Funding:
255.49 K USD
Similar Organizations
ActoBio Therapeutics
ActoBio Therapeutics develops therapeutic agents that treat a number of diseases, primarily on disease areas with high unmet needs.
MediCircle
MediCircle utilizes technology to eliminate barriers to care and reduce pharmaceutical waste.
Parvus Therapeutics
Parvus Therapeutics is a novel class of therapeutics to reverse autoimmune disease without impairing normal immunity.
Investors List
National Science Foundation
National Science Foundation investment in Grant - Akttyva Therapeutics
MassChallenge
MassChallenge investment in Non Equity Assistance - Akttyva Therapeutics
Official Site Inspections
http://www.akttyva.com
- Host name: a16e665f42988324c.awsglobalaccelerator.com
- IP address: 13.248.243.5
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Akttyva Therapeutics"
Akttyva Therapeutics
Akttyva Therapeutics co-founders have developed an evidence-based drug-discovery platform based on decades of expertise in biology, drug discovery and computational science. The platform is based on integrated AI tools and …See details»
About us - Akttyva Therapeutics
He currently serves as Scientific Advisor for Akttyva. Show Less. Mark Tepper, Ph.D. Mark Tepper, Ph.D. Mark Tepper, Ph.D. Board Chairman. Dr. Tepper has over 30 years of experience in the biotechnology and pharmaceutical industry. …See details»
Akttyva Therapeutics - Crunchbase Company Profile & Funding
When was the last funding round for Akttyva Therapeutics? Akttyva Therapeutics closed its last funding round on Nov 30, 2021 from a Grant round. Who are Akttyva Therapeutics 's …See details»
Akttyva Therapeutics Company Profile 2025: Valuation, Funding ...
Akttyva Therapeutics General Information Description. Developer of targeted therapeutics designed to address vascular barrier disorders. The company's therapeutics harness the …See details»
Akttyva Therapeutics - LinkedIn
Akttyva Therapeutics, Inc. is an NSF-funded company focused on discovery and development of therapies for unmet medical needs using a suite of proprietary computational tools and unique …See details»
Akttyva Therapeutics - Funding, Financials, Valuation & Investors
Akttyva Therapeutics develops targeted therapeutics that address cell barrier dysfunction across multiple indications. Search Crunchbase. Start Free Trial . ... How much funding has this …See details»
Akttyva Therapeutics - Contacts, Employees, Board Members
Akttyva Therapeutics develops targeted therapeutics that address cell barrier dysfunction across multiple indications.See details»
AKTTYVA THERAPEUTICS, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for AKTTYVA THERAPEUTICS, INC. of Watertown, MA. Get the latest business insights from Dun & …See details»
Akttyva Therapeutics - Products, Competitors, Financials, …
About Akttyva Therapeutics. Akttyva Therapeutics operates as a drug-discovery company focused on the development of targeted therapeutics. The company offers an artificial intelligence (AI) …See details»
AKTTYVA THERAPEUTICS, INC. - National Science Foundation
These topic labels come from the works of this organization's members. Together they form a unique fingerprint. Azide Pharmacology, Toxicology and Pharmaceutical Science 100%. …See details»
Akttyva Therapeutics - Company Profile & Staff Directory
Akttyva Therapeutics, Inc. is an NSF-funded company focused on discovery and development of therapies for unmet medical needs using a suite of proprietary computational tools and unique …See details»
Join our team - Akttyva Therapeutics
Akttyva Therapeutics is looking for several talented individuals to join our growing team in Mansfield, MA. Computational Scientist. If you have an advanced degree (Ph. D. or M.S.) in …See details»
NSF Award Search: Award # 2136307 - NSF - National Science …
Jul 3, 2023 Akttyva has developed several novel compound collections (using chemoinformatics and AI-assisted approaches), and an active-learning docking-scoring approach that screens …See details»
Akttyva Therapeutics - Tech Stack, Apps, Patents & Trademarks
Organization. Akttyva Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. IT Spend by Aberdeen. Edit IT Spend by …See details»
News - Akttyva Therapeutics
August 15, 2024 Akttyva Therapeutics was awarded a highly competitive National Science Foundation Phase 2 Award. The $1,000,000 funding serves as an independent government …See details»
Akttyva Therapeutics - Updates, News, Events, Signals & Triggers
Akttyva Therapeutics is researching and developing MK2 activators for the treatment of vascular disorders and endothelial barrier dysfunctions. These MK2 activators, with a molecular weight …See details»
Company Spotlight: Akttyva Therapeutics, Inc. (Akttyva ... - Bio-Inc
Feb 16, 2022 Akttyva is growing and there are currently a couple of opportunities is to join working on the NSF grant and establishing new assays team collaboration and evidence …See details»
Kinase signaling as a drug target modality for regulation of …
The endothelial vascular permeability barrier has an important role throughout the body's extensive vasculature, and its disruption leads to vascular hyperpermeability (leakage), which …See details»
KEY PUBLICATIONS - Akttyva Therapeutics
Vassiliou AG, Kotanidou A, Dimopoulou I, Orfanos SE. Endothelial Damage in Acute Respiratory Distress Syndrome. Int J Mol Sci. 2020 Nov 20;21(22):8793. doi: 10.3390/ijms21228793.See details»
Akttyva Therapeutics - Crunchbase
Akttyva Therapeutics, ActoBio Therapeutics, Parvus Therapeutics, and MediCircle are all involved in the biopharmaceutical industry. Akttyva and ActoBio focus on developing targeted …See details»